ACTA MEDICA, Vol 60 No 4 (2017), 152–156
Treatment of Multifocal Multisystem BRAF positive Langerhans Cell Histiocytosis with Cladribine, surgery and Allogenic Stem Cell Transplantation
Filip Gabalec, Martin Šimkovič, Alžběta Zavřelová, Petra Kašparová, Paula Morávková, Marcela Kopáčová, Václav Masopust, Pavel Žák, Jan Čáp, Jakub Radocha
DOI: https://doi.org/10.14712/18059694.2018.11
zveřejněno: 23. 04. 2018
Abstract
Langerhans cell histiocytosis (LCH) is a very rare disease in adults and as well a very rare cause of sellar expansion. The clinical presentation can be heterogeneous, from a single bone lesion to potentially fatal, widespread disease. We describe the difficulties with the diagnosis and treatment of LCH as well as successful treatment with cladribine chemotherapy and allogeneic stem cell transplantation.
klíčová slova: histiocytosis; transplantation; stem cell; cladribine; hypopituitarism
Treatment of Multifocal Multisystem BRAF positive Langerhans Cell Histiocytosis with Cladribine, surgery and Allogenic Stem Cell Transplantation is licensed under a Creative Commons Attribution 4.0 International License.
210 x 297 mm
vychází: 4 x ročně
cena tištěného čísla: 150 Kč
ISSN: 1211-4286
E-ISSN: 1805-9694